Leadership

Starting 1st September 2022, we are FVR – Finnish Vaccine Research: A special-assignment company of the state, with comprehensive expertise in vaccine research. We build on the solid foundation of vaccine research expertise of the Tampere University’s Vaccine Research Center and the Finnish Institute for Health and Welfare’s (THL) vaccine research.

Ownership
Finnish government 51%,
Tampere University Foundation 49%

BOARD OF DIRECTORS

  • Ms. Liisa-Maria Voipio-Pulkki, Chair of the Board,
    Ministry of Social Affairs and Health
  • Mr. Juhani Eskola, Independent
  • Mr. Tapio Visakorpi, Vice President of Tampere University
  • Ms. Sirpa Jalkanen, Academician, University of Turku
  • Ms. Saara Hassinen, CEO at Healthtech Finland

MANAGEMENT TEAM

  • Mr. Ilkka Haukijärvi, CEO
  • Mr. Mika Rämet, Chief Medical Officer
  • Mr. Arto Palmu, Chief Research Officer
  • Mr. Harri Leiviskä, Chief Financial and Administration Officer
  • Ms. Marikka Nevamäki, Chief Communications and Marketing Officer